1 Anticancer Drugs Market Overview 1.1 Product Overview and Scope of Anticancer Drugs 1.2 Anticancer Drugs Segment by Type 1.2.1 Global Anticancer Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) 1.2.3 Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) 1.2.4 Hormonal Drugs 1.3 Anticancer Drugs Segment by Application 1.3.1 Anticancer Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Lung Cancer 1.3.3 Breast Cancer 1.3.4 Leukemia 1.3.5 Colorectal Cancer 1.3.6 Other 1.4 Global Anticancer Drugs Market Size Estimates and Forecasts 1.4.1 Global Anticancer Drugs Revenue 2016-2027 1.4.2 Global Anticancer Drugs Sales 2016-2027 1.4.3 Anticancer Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Anticancer Drugs Market Competition by Manufacturers 2.1 Global Anticancer Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Anticancer Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Anticancer Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Anticancer Drugs Manufacturing Sites, Area Served, Product Type 2.5 Anticancer Drugs Market Competitive Situation and Trends 2.5.1 Anticancer Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Anticancer Drugs Players Market Share by Revenue 2.5.3 Global Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Anticancer Drugs Retrospective Market Scenario by Region 3.1 Global Anticancer Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Anticancer Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Anticancer Drugs Market Facts & Figures by Country 3.3.1 North America Anticancer Drugs Sales by Country 3.3.2 North America Anticancer Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Anticancer Drugs Market Facts & Figures by Country 3.4.1 Europe Anticancer Drugs Sales by Country 3.4.2 Europe Anticancer Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Anticancer Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Anticancer Drugs Sales by Region 3.5.2 Asia Pacific Anticancer Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Anticancer Drugs Market Facts & Figures by Country 3.6.1 Latin America Anticancer Drugs Sales by Country 3.6.2 Latin America Anticancer Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Anticancer Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Anticancer Drugs Sales by Country 3.7.2 Middle East and Africa Anticancer Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Anticancer Drugs Historic Market Analysis by Type 4.1 Global Anticancer Drugs Sales Market Share by Type (2016-2021) 4.2 Global Anticancer Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Anticancer Drugs Price by Type (2016-2021) 5 Global Anticancer Drugs Historic Market Analysis by Application 5.1 Global Anticancer Drugs Sales Market Share by Application (2016-2021) 5.2 Global Anticancer Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Anticancer Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 F. Hoffmann-La Roche Ltd 6.1.1 F. Hoffmann-La Roche Ltd Corporation Information 6.1.2 F. Hoffmann-La Roche Ltd Description and Business Overview 6.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 F. Hoffmann-La Roche Ltd Product Portfolio 6.1.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates 6.2 Eli Lilly and Company 6.2.1 Eli Lilly and Company Corporation Information 6.2.2 Eli Lilly and Company Description and Business Overview 6.2.3 Eli Lilly and Company Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Eli Lilly and Company Product Portfolio 6.2.5 Eli Lilly and Company Recent Developments/Updates 6.3 CELGENE CORPORATION 6.3.1 CELGENE CORPORATION Corporation Information 6.3.2 CELGENE CORPORATION Description and Business Overview 6.3.3 CELGENE CORPORATION Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 CELGENE CORPORATION Product Portfolio 6.3.5 CELGENE CORPORATION Recent Developments/Updates 6.4 Novartis AG 6.4.1 Novartis AG Corporation Information 6.4.2 Novartis AG Description and Business Overview 6.4.3 Novartis AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Novartis AG Product Portfolio 6.4.5 Novartis AG Recent Developments/Updates 6.5 Pfizer Inc 6.5.1 Pfizer Inc Corporation Information 6.5.2 Pfizer Inc Description and Business Overview 6.5.3 Pfizer Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Pfizer Inc Product Portfolio 6.5.5 Pfizer Inc Recent Developments/Updates 6.6 Amgen Inc 6.6.1 Amgen Inc Corporation Information 6.6.2 Amgen Inc Description and Business Overview 6.6.3 Amgen Inc Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Amgen Inc Product Portfolio 6.6.5 Amgen Inc Recent Developments/Updates 6.7 Bayer AG 6.6.1 Bayer AG Corporation Information 6.6.2 Bayer AG Description and Business Overview 6.6.3 Bayer AG Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bayer AG Product Portfolio 6.7.5 Bayer AG Recent Developments/Updates 6.8 AstraZeneca 6.8.1 AstraZeneca Corporation Information 6.8.2 AstraZeneca Description and Business Overview 6.8.3 AstraZeneca Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 AstraZeneca Product Portfolio 6.8.5 AstraZeneca Recent Developments/Updates 6.9 Takeda Pharmaceutical Company Limited 6.9.1 Takeda Pharmaceutical Company Limited Corporation Information 6.9.2 Takeda Pharmaceutical Company Limited Description and Business Overview 6.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Takeda Pharmaceutical Company Limited Product Portfolio 6.9.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates 6.10 Merck & Co. 6.10.1 Merck & Co. Corporation Information 6.10.2 Merck & Co. Description and Business Overview 6.10.3 Merck & Co. Anticancer Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Merck & Co. Product Portfolio 6.10.5 Merck & Co. Recent Developments/Updates 7 Anticancer Drugs Manufacturing Cost Analysis 7.1 Anticancer Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Anticancer Drugs 7.4 Anticancer Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Anticancer Drugs Distributors List 8.3 Anticancer Drugs Customers 9 Anticancer Drugs Market Dynamics 9.1 Anticancer Drugs Industry Trends 9.2 Anticancer Drugs Growth Drivers 9.3 Anticancer Drugs Market Challenges 9.4 Anticancer Drugs Market Restraints 10 Global Market Forecast 10.1 Anticancer Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Anticancer Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Anticancer Drugs by Type (2022-2027) 10.2 Anticancer Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Anticancer Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Anticancer Drugs by Application (2022-2027) 10.3 Anticancer Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Anticancer Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Anticancer Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Anticancer Drugs Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Anticancer Drugs Sales (MT) Comparison by Application (2021-2027) Table 3. Global Anticancer Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Anticancer Drugs Covered in This Study Table 5. Global Anticancer Drugs Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global Anticancer Drugs Sales Share by Manufacturers (2016-2021) Table 7. Global Anticancer Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Anticancer Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Anticancer Drugs Average Price (USD/Kg) of Key Manufacturers (2016-2021) Table 10. Manufacturers Anticancer Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Anticancer Drugs Product Type Table 12. Global Anticancer Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Anticancer Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticancer Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Anticancer Drugs Sales by Region (2016-2021) & (MT) Table 16. Global Anticancer Drugs Sales Market Share by Region (2016-2021) Table 17. Global Anticancer Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 19. North America Anticancer Drugs Sales Market Share by Country (2016-2021) Table 20. North America Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Anticancer Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 23. Europe Anticancer Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Anticancer Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Anticancer Drugs Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific Anticancer Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Anticancer Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Anticancer Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 31. Latin America Anticancer Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Anticancer Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Anticancer Drugs Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa Anticancer Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Anticancer Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Anticancer Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Anticancer Drugs Sales (MT) by Type (2016-2021) Table 39. Global Anticancer Drugs Sales Market Share by Type (2016-2021) Table 40. Global Anticancer Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Anticancer Drugs Revenue Share by Type (2016-2021) Table 42. Global Anticancer Drugs Price (USD/Kg) by Type (2016-2021) Table 43. Global Anticancer Drugs Sales (MT) by Application (2016-2021) Table 44. Global Anticancer Drugs Sales Market Share by Application (2016-2021) Table 45. Global Anticancer Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Anticancer Drugs Revenue Share by Application (2016-2021) Table 47. Global Anticancer Drugs Price (USD/Kg) by Application (2016-2021) Table 48. F. Hoffmann-La Roche Ltd Corporation Information Table 49. F. Hoffmann-La Roche Ltd Description and Business Overview Table 50. F. Hoffmann-La Roche Ltd Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 51. F. Hoffmann-La Roche Ltd Anticancer Drugs Product Table 52. F. Hoffmann-La Roche Ltd Recent Developments/Updates Table 53. Eli Lilly and Company Corporation Information Table 54. Eli Lilly and Company Description and Business Overview Table 55. Eli Lilly and Company Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 56. Eli Lilly and Company Anticancer Drugs Product Table 57. Eli Lilly and Company Recent Developments/Updates Table 58. CELGENE CORPORATION Corporation Information Table 59. CELGENE CORPORATION Description and Business Overview Table 60. CELGENE CORPORATION Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 61. CELGENE CORPORATION Anticancer Drugs Product Table 62. CELGENE CORPORATION Recent Developments/Updates Table 63. Novartis AG Corporation Information Table 64. Novartis AG Description and Business Overview Table 65. Novartis AG Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 66. Novartis AG Anticancer Drugs Product Table 67. Novartis AG Recent Developments/Updates Table 68. Pfizer Inc Corporation Information Table 69. Pfizer Inc Description and Business Overview Table 70. Pfizer Inc Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 71. Pfizer Inc Anticancer Drugs Product Table 72. Pfizer Inc Recent Developments/Updates Table 73. Amgen Inc Corporation Information Table 74. Amgen Inc Description and Business Overview Table 75. Amgen Inc Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 76. Amgen Inc Anticancer Drugs Product Table 77. Amgen Inc Recent Developments/Updates Table 78. Bayer AG Corporation Information Table 79. Bayer AG Description and Business Overview Table 80. Bayer AG Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 81. Bayer AG Anticancer Drugs Product Table 82. Bayer AG Recent Developments/Updates Table 83. AstraZeneca Corporation Information Table 84. AstraZeneca Description and Business Overview Table 85. AstraZeneca Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 86. AstraZeneca Anticancer Drugs Product Table 87. AstraZeneca Recent Developments/Updates Table 88. Takeda Pharmaceutical Company Limited Corporation Information Table 89. Takeda Pharmaceutical Company Limited Description and Business Overview Table 90. Takeda Pharmaceutical Company Limited Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 91. Takeda Pharmaceutical Company Limited Anticancer Drugs Product Table 92. Takeda Pharmaceutical Company Limited Recent Developments/Updates Table 93. Merck & Co. Corporation Information Table 94. Merck & Co. Description and Business Overview Table 95. Merck & Co. Anticancer Drugs Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021) Table 96. Merck & Co. Anticancer Drugs Product Table 97. Merck & Co. Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Anticancer Drugs Distributors List Table 101. Anticancer Drugs Customers List Table 102. Anticancer Drugs Market Trends Table 103. Anticancer Drugs Growth Drivers Table 104. Anticancer Drugs Market Restraints Table 105. Global Anticancer Drugs Sales Forecast by Type (2022-2027) & (MT) Table 106. Global Anticancer Drugs Sales Market Share Forecast by Type (2022-2027) Table 107. Global Anticancer Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Anticancer Drugs Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Anticancer Drugs Sales Forecast by Application (2022-2027) & (MT) Table 110. Global Anticancer Drugs Sales Market Share Forecast by Application (2022-2027) Table 111. Global Anticancer Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Anticancer Drugs Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Anticancer Drugs Sales Forecast by Region (2022-2027) & (MT) Table 114. Global Anticancer Drugs Sales Market Share Forecast by Region (2022-2027) Table 115. Global Anticancer Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Anticancer Drugs Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Anticancer Drugs Figure 2. Global Anticancer Drugs Market Share by Type in 2020 & 2027 Figure 3. Cytotoxic Drugs (Alkylating Agents, and Antimetabolites) Product Picture Figure 4. Targeted Drugs (Monoclonal Antibodies and Tyrosine Kinase Inhibitors) Product Picture Figure 5. Hormonal Drugs Product Picture Figure 6. Global Anticancer Drugs Market Share by Application in 2020 & 2027 Figure 7. Lung Cancer Figure 8. Breast Cancer Figure 9. Leukemia Figure 10. Colorectal Cancer Figure 11. Other Figure 12. Global Anticancer Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Anticancer Drugs Market Size 2016-2027 (US$ Million) Figure 14. Global Anticancer Drugs Sales 2016-2027 (MT) Figure 15. Global Anticancer Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. Anticancer Drugs Sales Share by Manufacturers in 2020 Figure 17. Global Anticancer Drugs Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest Anticancer Drugs Players: Market Share by Revenue in 2020 Figure 19. Anticancer Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global Anticancer Drugs Sales Market Share by Region (2016-2021) Figure 21. Global Anticancer Drugs Sales Market Share by Region in 2020 Figure 22. Global Anticancer Drugs Revenue Market Share by Region (2016-2021) Figure 23. Global Anticancer Drugs Revenue Market Share by Region in 2020 Figure 24. U.S. Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E Anticancer Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of Anticancer Drugs by Type (2016-2021) Figure 49. Sales Market Share of Anticancer Drugs by Application (2016-2021) Figure 50. Sales Market Share of Anticancer Drugs by Application in 2020 Figure 51. Revenue Share of Anticancer Drugs by Application (2016-2021) Figure 52. Revenue Share of Anticancer Drugs by Application in 2020 Figure 53. Manufacturing Cost Structure of Anticancer Drugs Figure 54. Manufacturing Process Analysis of Anticancer Drugs Figure 55. Anticancer Drugs Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

F. Hoffmann-La Roche Ltd Eli Lilly and Company CELGENE CORPORATION Novartis AG Pfizer Inc Amgen Inc Bayer AG AstraZeneca Takeda Pharmaceutical Company Limited Merck & Co.